FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Neumaier

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Concepts & Ideas

Disorders

Colorectal Neoplasms

Procedures

Occupations

Proteomics

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Tina Fuchs; Alexei Gratchev; Martin Hahn; Alexander W Beham; Claudia Dollt; Alexander Emmert; Julian Fleig; Julia Kzhyshkowska; Michael Neumaier; Ilja Ovsiy; Ioanna Pechlivanidou; Kerstin Puellmann; Wolfgang E Kaminski
A second combinatorial immune receptor in monocytes/macrophages is based on the TCRγδ.
Paul Apfaltrer; Joachim Gruettner; Thomas Henzler; Mathias Meyer; Michael Neumaier; Stefan O Schoenberg; Thomas Walter; Frank Weilbacher; Christian Fink
Prediction of adverse clinical outcome in patients with acute pulmonary embolism: evaluation of high-sensitivity troponin I and quantitative CT parameters.
Mathias Meyer; Michael Neumaier; Susanne Roeger; Stefan O Schoenberg; Paul Apfaltrer; Christian Fink; Dariusch Haghi; Wolfgang E Kaminski; Thomas Henzler
Benefit of combining quantitative cardiac CT parameters with troponin I for predicting right ventricular dysfunction and adverse clinical events in patients with acute pulmonary embolism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Neumaier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tina Fuchs; Alexei Gratchev; Martin Hahn; Alexander W Beham; Claudia Dollt; Alexander Emmert; Julian Fleig; Julia Kzhyshkowska; Michael Neumaier; Ilja Ovsiy; Ioanna Pechlivanidou; Kerstin Puellmann; Wolfgang E Kaminski
A second combinatorial immune receptor in monocytes/macrophages is based on the TCRγδ.
Immunobiology 2013;218(7):960-8.
2013: Paul Apfaltrer; Joachim Gruettner; Thomas Henzler; Mathias Meyer; Michael Neumaier; Stefan O Schoenberg; Thomas Walter; Frank Weilbacher; Christian Fink
Prediction of adverse clinical outcome in patients with acute pulmonary embolism: evaluation of high-sensitivity troponin I and quantitative CT parameters.
European journal of radiology 2013;82(3):563-7.
2012: Mathias Meyer; Michael Neumaier; Susanne Roeger; Stefan O Schoenberg; Paul Apfaltrer; Christian Fink; Dariusch Haghi; Wolfgang E Kaminski; Thomas Henzler
Benefit of combining quantitative cardiac CT parameters with troponin I for predicting right ventricular dysfunction and adverse clinical events in patients with acute pulmonary embolism.
European journal of radiology 2012;81(11):3294-9.
2012: Jost B Jonas; Rahul A Jonas; Michael Neumaier; Peter Findeisen
Cytokine concentration in aqueous humor of eyes with diabetic macular edema.
Retina (Philadelphia, Pa.) 2012;32(10):2150-7.
2012: Parviz Ahmad-Nejad; Martin Borggrefe; Peter Bugert; Carl-Erik Dempfle; Christel Weiss; Michael Neumaier
The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events.
Thrombosis research 2012;130(3):441-4.
2012: Jost B Jonas; Michael Neumaier; Yong Tao; Peter Findeisen
Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration.
Acta ophthalmologica 2012;90(5):e381-8.
2012: Tina Fuchs; Alexander W Beham; Jens Kruth; Michael Neumaier; Kerstin Puellmann; Sven Schneider; Torsten J Schulze; Wolfgang E Kaminski
An autoimmune double attack.
Lancet 2012;379(9823):1364.
2012: Tina Fuchs; Arnold Ganser; Alexei Gratchev; Julia Kzhyshkowska; Michael Neumaier; Ioanna Pechlivanidou; Kerstin Püellmann; Olivia Scharfenstein; Elfi Stobe; Anna Becker; Alexander W Beham; Romy Eichner; Wolfgang E Kaminski
The neutrophil recombinatorial TCR-like immune receptor is expressed across the entire human life span but repertoire diversity declines in old age.
Biochemical and biophysical research communications 2012;419(2):309-15.
2012: Christian Neumaier; Stefanie Nittka; Michael Neumaier
Loss of expression of the tumor suppressor CEACAM1 links different hereditary colorectal carcinoma subtypes to the genesis of sporadic colorectal carcinoma.
Onkologie 2012;35(10):563-8.
2012: Peter Findeisen; Ralf Hofheinz; Victor Costina; Diego Yepes; Michael Neumaier
Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.
Journal of experimental & clinical cancer research : CR 2012;31():56.
2012: Peter Findeisen; Michael Neumaier
Functional protease profiling for diagnosis of malignant disease.
Proteomics. Clinical applications 2012;6(1-2):60-78.
2011: Alexander W Beham; Caroline Breysach; Peter Findeisen; Tina Fuchs; Arnold Ganser; Alexei Gratchev; Heinz Becker; Joseph Keane; Julia Kzhyshkowska; Rebecca Laird; Wiebke Möbius; Michael Neumaier; Septimia Oniga; Teresa Peccerella; Kerstin Puellmann; Dirk Raddatz; Bernadette Saunders; Stefan Schweyer; Roswita Streich; Johannes T Wessels; Wolfgang E Kaminski
A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis.
PLoS pathogens 2011;7(11):e1002375.
2011: Tobias Benjamin Schuster; Victor Costina; Peter Findeisen; Michael Neumaier; Parviz Ahmad-Nejad
Identification and functional characterization of 14-3-3 in TLR2 signaling.
Journal of proteome research 2011;10(10):4661-70.
2011: Michael Neumaier; Michael A Scherer; T Freude; F Martetschläger; H Vester; Ulrich Stöckle
[Optimal timing of operations to treat fractures of the femoral neck with endoprotheses : CRP as a parameter of postoperative immunologic reaction].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2011;82(10):921-6.
2011: Parviz Ahmad-Nejad; Peter Bugert; Christof Denz; Michael Quintel; Jennifer Wacker; Christel Weiss; Wilma Zimmer; Michael Neumaier
The presence of functionally relevant toll-like receptor polymorphisms does not significantly correlate with development or outcome of sepsis.
Genetic testing and molecular biomarkers 2011;15(9):645-51.
2011: Diego Yepes; Anette Jacob; Marc Dauber; Victor Costina; Ralf Hofheinz; Michael Neumaier; Peter Findeisen
Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
International journal of oncology 2011;39(1):145-54.
2011: Michael Behnes; Ursula Hoffmann; Siegfried Lang; Christel Weiss; Parviz Ahmad-Nejad; Michael Neumaier; Martin Borggrefe; Martina Brueckmann
Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(4):335-42.
2011: Hanne Boll; Fabian Doyon; Christoph Groden; Martin Kramer; Alexander Marx; Michael Neumaier; Stefanie Nittka; Marc A Brockmann
Micro-CT based experimental liver imaging using a nanoparticulate contrast agent: a longitudinal study in mice.
PloS one 2011;6(9):e25692.
2010: M D Schmittner; Jörg Faulhaber; B Kemler; Wolfgang Koenen; J O Thumfart; Christel Weiss; Michael Neumaier; G C Beck
Influence of high dose tumescent local anaesthesia with prilocaine on systemic interleukin (IL)-6, IL-8 and tumour necrosis factor-α.
Journal of the European Academy of Dermatology and Venereology : JEADV 2010;24(12):1400-5.
2010: Andrew Kubarenko; Satish Ranjan; Anna Rautanen; Tara C Mills; Sunny Wong; Fredrik Vannberg; Michael Neumaier; Isabelle Bekeredjian-Ding; Adrian V S Hill; Parviz Ahmad-Nejad; Alexander N R Weber
A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.
The Journal of biological chemistry 2010;285(47):36486-94.
2010: Miriam Reuschenbach; Matthias Kloor; Monika Morak; Nicolas Wentzensen; Anja Germann; Yvette Garbe; Mirjam Tariverdian; Peter Findeisen; Michael Neumaier; Elke Holinski-Feder; Magnus von Knebel Doeberitz
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.
Familial cancer 2010;9(2):173-9.
2010: Teresa Peccerella; Nadine Lukan; Ralf Hofheinz; Dirk Schadendorf; Markus Kostrezewa; Michael Neumaier; Peter Findeisen
Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology.
Clinical chemistry 2010;56(2):272-80.
2010: Martina Deinzer; Ralf Faissner; Tobias Metzger; Wolfgang E Kaminski; Matthias Löhr; Michael Neumaier; Thomas Brinkmann
Comparison of two different methods for CA19-9 antigen determination.
Clinical laboratory 2010;56(7-8):319-25.
2009: Carl-Erik Dempfle; Ulyana Zharkowa; Elif Elmas; Parviz Ahmad-Nejad; Michael Neumaier; Martin Borggrefe
Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
Thrombosis and haemostasis 2009;102(5):1001-6.
2009: Peter Findeisen; Michael Neumaier
Mass spectrometry-based clinical proteomics profiling: current status and future directions.
Expert review of proteomics 2009;6(5):457-9.
2009: Rolf Apweiler; Charalampos Aslanidis; Thomas Deufel; Andreas Gerstner; Jens Hansen; Dennis Hochstrasser; Roland Kellner; Markus Kubicek; Friedrich Lottspeich; Edmund Maser; Hans-Werner Mewes; Helmut E Meyer; Stefan Müllner; Wolfgang Mutter; Michael Neumaier; Peter Nollau; Hans G Nothwang; Fredrik Ponten; Andreas Radbruch; Knut Reinert; Gregor Rothe; Hannes Stockinger; Attila Tárnok; Mike J Taussig; Andreas Thiel; Joachim Thiery; Marius Ueffing; Günther Valet; Joel Vandekerckhove; Christoph Wagener; Oswald Wagner; Gerd Schmitz
Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2009;75(10):816-32.
2009: Carl-Erik Dempfle; Julia Eichner; Nenad Suvajac; Parviz Ahmad-Nejad; Michael Neumaier; Martin Borggrefe
The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
Anesthesia and analgesia 2009;109(3):712-6.
2009: Carl-Erik Dempfle; Peter M George; Martin Borggrefe; Michael Neumaier; Stephen O Brennan
Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: fibrinogen Mannheim V.
Thrombosis and haemostasis 2009;102(1):29-34.
2009: Michael Behnes; Martina Brueckmann; Parviz Ahmad-Nejad; Siegfried Lang; Christian Wolpert; Elif Elmas; Thorsten Kaelsch; Joachim Gruettner; Christel Weiss; Martin Borggrefe; Michael Neumaier
Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
International journal of cardiology 2009;135(2):165-74.
2009: Madlen Neustadt; Victor Costina; Claudio Kupfahl; Dieter Buchheidt; Christoph Eckerskorn; Michael Neumaier; Peter Findeisen
Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS.
Electrophoresis 2009;30(12):2142-50.
2009: Peter Findeisen; Marc Zapatka; Teresa Peccerella; Heike Matzk; Michael Neumaier; Dirk Schadendorf; Selma Ugurel
Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2199-208.
2009: Francois Rousseau; David Gancberg; Heinz Schimmel; Michael Neumaier; Alexandre Bureau; Cyril Mamotte; Ron van Schaik; Deborah Payne; Mario Pazzagli; Ian Young
Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory Medicine.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1343-50.
2009: Rolf Apweiler; Charalampos Aslanidis; Thomas Deufel; Andreas O H Gerstner; Jens Hansen; Dennis Hochstrasser; Roland Kellner; Markus Kubicek; Friedrich Lottspeich; Edmund Maser; Hans-Werner Mewes; Helmut E Meyer; Stefan Müllner; Wolfgang Mutter; Michael Neumaier; Peter Nollau; Hans G Nothwang; Fredrik Ponten; Andreas Radbruch; Knut Reinert; Gregor Rothe; Hannes Stockinger; Attila Tárnok; Mike J Taussig; Andreas Thiel; Joachim Thiery; Marius Ueffing; Günther Valet; Joel Vandekerckhove; Wiltrud Verhuven; Christoph Wagener; Oswald Wagner; Gerd Schmitz
Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(6):724-44.
2009: Peter Findeisen; Michael Neumaier
Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(6):666-84.
2008: Peter Findeisen; Matthias Röckel; Matthias Nees; Christian Röder; Peter Kienle; Magnus von Knebel Doeberitz; Holger Kalthoff; Michael Neumaier
Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
International journal of oncology 2008;33(5):1001-10.
2008: Michael Behnes; Siegfried Lang; Ole-A. Breithardt; Jens J Kaden; Dariusch Haghi; Parviz Ahmad-Nejad; Elif Elmas; Christian Wolpert; Martin Borggrefe; Michael Neumaier; Martina Brueckmann
Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
The Journal of heart valve disease 2008;17(5):557-65.
2008: Claus-Detlev Klemke; J Brade; S Weckesser; M M Sachse; N Booken; Michael Neumaier; Sergij Goerdt; T C Nebe
The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
The British journal of dermatology 2008;159(4):871-80.
2008: C-E Dempfle; T Frietsch; T Hoffmann; P Ahmad-Nejad; Michael Neumaier; M Borggrefe
Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(5):1147-9.
2008: S Nittka; Christoph K Böhm; Hanswalter Zentgraf; Michael Neumaier
The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1.
Oncogene 2008;27(26):3721-8.
2008: Peter Findeisen; Teresa Peccerella; Stefan Post; Frederik Wenz; Michael Neumaier
Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
Rapid communications in mass spectrometry : RCM 2008;22(8):1223-9.
2008: Paolo Verderio; Simon C Ramsden; Claudio Orlando; Sara Pizzamiglio; angelo paradiso; Michael Neumaier; Mario Pazzagli; Ettore Marubini
External quality assessment schemes for real-time PCR: a statistical procedure to corrective actions.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(5):717-21.
2008: Elif Elmas; Parviz Ahmad-Nejad; Christel Weiss; Michael Neumaier; Martin Borggrefe
Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(9):1329-31.
2008: Georg Hoffmann; Rasso Ostermeir; Holger Müller; Norman Bitterlich; Peter Martus; Michael Neumaier
SimChip--computer simulation of mRNA steady states.
Clinical laboratory 2008;54(1-2):19-24.
2007: René Schaal; Claudio Kupfahl; Dieter Buchheidt; Michael Neumaier; Peter Findeisen
Systematic identification of substrates for profiling of secreted proteases from Aspergillus species.
Journal of microbiological methods 2007;71(2):93-100.
2007: Peter Findeisen; Stefan Post; Frederik Wenz; Michael Neumaier
Addition of exogenous reporter peptides to serum samples before mass spectrometry-based protease profiling provides advantages over profiling of endogenous peptides.
Clinical chemistry 2007;53(10):1864-6.
2007: Florian Streitner; Juergen Kuschyk; Christian Veltmann; Martina Brueckmann; Ines Streitner; Joachim Brade; Michael Neumaier; Thomas Bertsch; Burghard Schumacher; Martin Borggrefe; Christian Wolpert
Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
Cytokine 2007;40(1):30-4.
2007: Sibylle Sauerhöfer; Gang Yuan; Gerald S Braun; Martina Deinzer; Michael Neumaier; Norbert Gretz; Jürgen Floege; Wilhelm Kriz; Fokko J van der Woude; Marcus J Moeller
L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.
Diabetes 2007;56(10):2425-32.
2007: Claudio Orlando; Paolo Verderio; Ronald Maatman; Jan Danneberg; Simon Ramsden; Michael Neumaier; Domenica Taruscio; Vincenzo Falbo; Robert Jansen; Claudia Casini Raggi; Francesca Malentacchi; Ettore Marubini; Sara Pizzamiglio; Kris Vernelen; Jean-Claude Libeer; Vladimír Palicka; Mario Pazzagli
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification.
Clinical chemistry 2007;53(7):1349-57.
2007: Martin Griebe; Michael Daffertshofer; Mark Stroick; Magdalena Syren; Parviz Ahmad-Nejad; Michael Neumaier; Juergen Backhaus; Michael G Hennerici; Marc Fatar
Infrared spectroscopy: a new diagnostic tool in Alzheimer disease.
Neuroscience letters 2007;420(1):29-33.
2007: Sabine Merx; Michael Neumaier; Hermann Wagner; Carsten J Kirschning; Parviz Ahmad-Nejad
Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene.
Human molecular genetics 2007;16(10):1225-32.
2007: Jost B Jonas; Michael Neumaier
Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy.
Clinical & experimental ophthalmology 2007;35(2):186-7.
2007: Elif Elmas; Thorsten Kälsch; Nenad Suvajac; Hans Leweling; Michael Neumaier; Carl-Erik Dempfle; Martin Borggrefe
Activation of coagulation during alimentary lipemia under real-life conditions.
International journal of cardiology 2007;114(2):172-5.
2007: Jost B Jonas; Michael Neumaier
Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema.
Ophthalmic research 2007;39(3):139-42.
2006: Alexandra Dorn-Beineke; Parviz Ahmad-Nejad; Ulrike Pfeiffer; Simon Ramsden; Mario Pazzagli; Michael Neumaier
Improvement of technical and analytical performance in DNA sequencing by external quality assessment-based molecular training.
Clinical chemistry 2006;52(11):2072-8.
2006: Simon Ramsden; Sarah Daly; Wolf-Jochen Geilenkeuser; Graeme Duncan; fabienne hermitte; Ettore Marubini; Michael Neumaier; Claudio Orlando; Vladimír Palicka; angelo paradiso; Mario Pazzagli; Sara Pizzamiglio; Paolo Verderio
EQUAL-quant: an international external quality assessment scheme for real-time PCR.
Clinical chemistry 2006;52(8):1584-91.
2006: J M Löhr; R Faissner; Peter Findeisen; Michael Neumaier
[Proteome analysis--basis for individualized pancreatic carcinoma therapy?].
Der Internist 2006;47 Suppl 1():S40-8.
2006: Parviz Ahmad-Nejad; Alexandra Dorn-Beineke; Ulrike Pfeiffer; Joachim Brade; Wolf-Jochen Geilenkeuser; Simon Ramsden; Mario Pazzagli; Michael Neumaier
Methodologic European external quality assurance for DNA sequencing: the EQUALseq program.
Clinical chemistry 2006;52(4):716-27.
2006: Sabine Merx; Wilma Zimmer; Michael Neumaier; Parviz Ahmad-Nejad
Characterization and functional investigation of single nucleotide polymorphisms (SNPs) in the human TLR5 gene.
Human mutation 2006;27(3):293.
2005: Peter Findeisen; Diamandula Sismanidis; Martin Riedl; Victor Costina; Michael Neumaier
Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Clinical chemistry 2005;51(12):2409-11.
2005: Christian Schwegler; Alexandra Dorn-Beineke; Stefanie Nittka; Carol Stocking; Michael Neumaier
Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Cancer research 2005;65(5):1925-33.
2005: Christoph L Klein; János Márki-Zay; Philippe Corbisier; David Gancberg; Susan Cooper; Donato Gemmati; Walter-Michael Halbmayer; Steve Kitchen; Béla Melegh; Michael Neumaier; Johannes Oldenburg; Elisabeth Oppliger Leibundgut; Pieter H Reitsma; Sandra Rieger; Heinz Schimmel; Michael Spannagl; Attilia Tordai; Alberto Tosetto; Sophie Visvikis; Renata Zadro; Christine Mannhalter
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(8):862-8.
2005: C Thomas Nebe; Marion Rother; Ingrid Brechtel; Victor Costina; Michael Neumaier; Hanswalter Zentgraf; Ulrich Böcker; Thomas F Meyer; Agnieszka Szczepek
Detection of Chlamydophila pneumoniae in the bone marrow of two patients with unexplained chronic anaemia.
European journal of haematology 2005;74(1):77-83.
2004: Stefanie Nittka; Juliane Günther; Cornelia Ebisch; Andreas Erbersdobler; Michael Neumaier
The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.
Oncogene 2004;23(58):9306-13.
2004: George A Abou-Rjaily; Sang Jun Lee; Denisa May; Qusai Y Al-Share; Anthony M Deangelis; Randall J Ruch; Michael Neumaier; Holger Kalthoff; Sue-Hwa Lin; Sonia M Najjar
CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
The Journal of clinical investigation 2004;114(7):944-52.
2004: Martina Brueckmann; Christian Wolpert; Thomas Bertsch; Tim Sueselbeck; Claudia Liebetrau; Jens J Kaden; Guenter Huhle; Michael Neumaier; Martin Borggrefe; Karl K Haase
Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias.
Journal of cardiovascular electrophysiology 2004;15(6):686-91.
2004: Marcus Katoh; Michael Neumaier; R Nezam; Jakob R Izbicki; Udo Schumacher
Correlation of circulating tumor cells with tumor size and metastatic load in a spontaneous lung metastasis model.
Anticancer research 2004;24(3a):1421-5.
2004: Parviz Ahmad-Nejad; Salima Mrabet-Dahbi; Kristine Breuer; Martina Klotz; Thomas Werfel; Udo Herz; Klaus Heeg; Michael Neumaier; Harald Renz
The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype.
The Journal of allergy and clinical immunology 2004;113(3):565-7.
2003: Hans-Peter Hammes; Xue-Liang Du; Diane Edelstein; Tetsuya Taguchi; Takeshi Matsumura; Qida Ju; Jihong Lin; Angelika Bierhaus; Peter Nawroth; Dieter Hannak; Michael Neumaier; Regine Bergfeld; Ida Giardino; Michael Brownlee
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Nature medicine 2003;9(3):294-9.
2001: Michael A Scherer; Michael Neumaier; S von Gumppenberg
C-reactive protein in patients who had operative fracture treatment.
Clinical orthopaedics and related research 2001;(393):287-93.
2001: Arnd S Boehle; Roland Kurdow; M Schulze; U Kliche; Bence Sipos; K Soondrum; A Ebrahimnejad; Peter Dohrmann; Holger Kalthoff; Doris Henne-Bruns; Michael Neumaier
Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model.
International journal of cancer. Journal international du cancer 2001;94(3):420-8.
2001: Edlyn Soeth; T Wirth; Heinz-Joachim List; S Kumbhani; A Petersen; Michael Neumaier; Frank Czubayko; Hartmut Juhl
Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):2022-30.
2001: P Hoffmann; N Mueller; J E Shively; B Fleischer; Michael Neumaier
Fusion proteins of B7.1 and a carcinoembryonic antigen (CEA)-specific antibody fragment opsonize CEA-expressing tumor cells and coactivate T-cell immunity.
International journal of cancer. Journal international du cancer 2001;92(5):725-32.
2001: K Haack; K Soondrum; Michael Neumaier
Detection of MetastaticTumor Cells in Blood by Reverse Transcriptase-Polymerase Chain Reaction.
Methods in molecular medicine 2001;57():285-95.
2001: R Jung; K Soondrum; W Krüger; Michael Neumaier
Detection of micrometastasis through tissue-specific gene expression: its promise and problems.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():32-9.
2000: R Jung; K Soondrum; Michael Neumaier
Quantitative PCR.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(9):833-6.
2000: Tammo von Schrenck; M Ahrens; Andreas de Weerth; C Bobrowski; Gunter Wolf; Ludwig Jonas; Thomas Jocks; Martina Schulz; Michael Bläker; Michael Neumaier; Rolf A K Stahl
CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney.
Kidney international 2000;58(3):995-1003.
2000: W Krüger; R Jung; N Kröger; Kai Gutensohn; W Fiedler; Michael Neumaier; Fritz Jänicke; Christoph Wagener; A R Zander
Sensitivity of assays designed for the detection of disseminated epithelial tumor cells is influenced by cell separation methods.
Clinical chemistry 2000;46(3):435-6.
2000: Michael Neumaier; A Braun; R Gessner; H Funke
Experiences with external quality assessment (EQA) in molecular diagnostics in clinical laboratories in Germany. Working Group of the German Societies for Clinical Chemistry (DGKC) and Laboratory Medicine (DGLM).
Clinical chemistry and laboratory medicine : CCLM / FESCC 2000;38(2):161-3.
1999: Nicole Beauchemin; P Draber; Gabriela S Dveksler; P Gold; Scott D Gray-Owen; Fritz Grunert; Sten Hammarström; K V Holmes; A Karlsson; M Kuroki; S H Lin; Lothar Lucka; S M Najjar; Michael Neumaier; Björn Obrink; J E Shively; Keith M Skubitz; Clifford P Stanners; P Thomas; J A Thompson; Mumtaz Virji; S von Kleist; Christoph Wagener; S Watt; Wolfgang Zimmermann
Redefined nomenclature for members of the carcinoembryonic antigen family.
Experimental cell research 1999;252(2):243-9.
1999: R Jung; K Petersen; W Krüger; M Wolf; Christoph Wagener; A Zander; Michael Neumaier
Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes.
British journal of cancer 1999;81(5):870-3.
1999: Michael Neumaier; F J Gaida; M R Lewis; LJ Hefta; LE Shively; A Raubitschek; John E Shively
A chimeric anti-CEA antibody with heavy interchain disulfide bonds deleted: molecular characterization and biodistributions in normal and tumor bearing mice.
Anticancer research 1999;19(1A):13-21.
1998: R Jung; W Krüger; S Hosch; M Holweg; N Kröger; Kai Gutensohn; Christoph Wagener; Michael Neumaier; A R Zander
Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro.
British journal of cancer 1998;78(9):1194-8.
1998: LJ Hefta; Michael Neumaier; John E Shively
Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.
Immunotechnology : an international journal of immunological engineering 1998;4(1):49-57.
1998: A Braun; T Deufel; Wolf-Jochen Geilenkeuser; Michael Neumaier; G Röhle; A Roscher; Christoph Wagener
External quality assessment of molecular biology-based methods used in laboratories of clinical chemistry and human genetics.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1998;36(4):231-4.
1998: Michael Neumaier; A Braun; Christoph Wagener
Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques.
Clinical chemistry 1998;44(1):12-26.
1997: Peter Tschentscher; Christoph Wagener; Michael Neumaier
Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA.
Clinical chemistry 1997;43(12):2244-50.
1997: Jeffrey Y C Wong; G E Thomas; Dave M Yamauchi; Lawrence E Williams; TL Odom-Maryon; An Liu; J M Esteban; Michael Neumaier; S Dresse; Anna M Wu; FJ Primus; John E Shively; Andrew Raubitschek
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1951-9.
1997: Peter Nollau; F Prall; U Helmchen; Christoph Wagener; Michael Neumaier
Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization.
The American journal of pathology 1997;151(2):521-30.
1997: R Jung; C Lübcke; C Wagener; Michael Neumaier
Reversal of RT-PCR inhibition observed in heparinized clinical specimens.
BioTechniques 1997;23(1):24, 26, 28.
1997: Peter Nollau; H Scheller; M Kona-Horstmann; S Rohde; Friedrich Hagenmüller; Christoph Wagener; Michael Neumaier
Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas.
Cancer research 1997;57(12):2354-7.
1997: R Jung; Parviz Ahmad-Nejad; M Wimmer; Markus Gerhard; Christoph Wagener; Michael Neumaier
Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(1):3-10.
1996: Dieter Metze; H P Soyer; B Zelger; Michael Neumaier; Fritz Grunert; C Hartig; U Amann; R Bhardwaj; C Wagener; Thomas Luger
Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker.
Journal of the American Academy of Dermatology 1996;34(5 Pt 1):735-44.
1996: Anna M Wu; W Chen; Andrew Raubitschek; Lawrence E Williams; Michael Neumaier; R Fischer; S Z Hu; TL Odom-Maryon; Jeffrey Y C Wong; John E Shively
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
Immunotechnology : an international journal of immunological engineering 1996;2(1):21-36.
1996: Dieter Metze; Fritz Grunert; Michael Neumaier; R Bhardwaj; U Amann; C Wagener; Thomas A Luger
Neoplasms with sweat gland differentiation express various glycoproteins of the carcinoembryonic antigen (CEA) family.
Journal of cutaneous pathology 1996;23(1):1-11.
1996: Karsten Neuber; B Berg-Drewniock; M Volkenandt; Michael Neumaier; W Zeller; G Gross; J Ring
B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Dermatology (Basel, Switzerland) 1996;192(2):110-5.
1996: Dieter Metze; R Bhardwaj; U Amann; A M Eades-Perner; Michael Neumaier; C Wagener; Peter Jantscheff; Fritz Grunert; Thomas A Luger
Glycoproteins of the carcinoembryonic antigen (CEA) family are expressed in sweat and sebaceous glands of human fetal and adult skin.
The Journal of investigative dermatology 1996;106(1):64-9.
1996: F Prall; Peter Nollau; Michael Neumaier; HD Haubeck; Z Drzeniek; U Helmchen; T Löning; Christoph Wagener
CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1996;44(1):35-41.
1995: Jeffrey Y C Wong; Lawrence E Williams; Dave M Yamauchi; TL Odom-Maryon; J M Esteban; Michael Neumaier; Anna M Wu; D K Johnson; FJ Primus; John E Shively
Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
Cancer research 1995;55(23 Suppl):5929s-5934s.
1995: J Brümmer; Michael Neumaier; C Göpfert; C Wagener
Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
Oncogene 1995;11(8):1649-55.
1995: Michael Neumaier; Markus Gerhard; Christoph Wagener
Diagnosis of micrometastases by the amplification of tissue-specific genes.
Gene 1995;159(1):43-7.
1995: Peter Nollau; R Jung; Michael Neumaier; Christoph Wagener
Tumour diagnosis by PCR-based detection of tumour cells.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1995;221():116-21.
1994: J Thompson; Wolfgang Zimmermann; Peter Nollau; Michael Neumaier; J Weber-Arden; H Schrewe; I Craig; T Willcocks
CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas.
The Journal of biological chemistry 1994;269(52):32924-31.
1994: A M Eades-Perner; H van der Putten; A Hirth; J Thompson; Michael Neumaier; S von Kleist; Wolfgang Zimmermann
Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.
Cancer research 1994;54(15):4169-76.
1994: Hartmut Juhl; M Stritzel; A Wroblewski; Doris Henne-Bruns; Bernd Kremer; Wolff Schmiegel; Michael Neumaier; Christoph Wagener; H W Schreiber; Holger Kalthoff
Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients.
International journal of cancer. Journal international du cancer 1994;57(3):330-5.
1994: Peter Tschentscher; Christoph Wagener; Michael Neumaier
Distinction of highly homologous pregnancy-specific glycoprotein (PSG) isoforms by differential absorption of antisera with recombinant PSG fusion protein domains.
Journal of immunological methods 1994;170(2):247-54.
1994: Markus Gerhard; Hartmut Juhl; Holger Kalthoff; H W Schreiber; Christoph Wagener; Michael Neumaier
Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):725-9.
1994: Christian Hagel; Michael Neumaier; Dimitrios Stavrou
Sequencing data of the antiglioma antibody MUC 2-63 and strategy for construction of chimeric antibodies.
Cell biophysics 1994;24-25():331-9.
1993: Michael Neumaier; S Paululat; A Chan; P Matthaes; Christoph Wagener
Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(22):10744-8.
1993: F J Gaida; D Pieper; U W Roder; John E Shively; Christoph Wagener; Michael Neumaier
Molecular characterization of a cloned idiotypic cascade containing a network antigenic determinant specific for the human carcinoembryonic antigen.
The Journal of biological chemistry 1993;268(19):14138-45.
1993: A Stoffel; Michael Neumaier; F J Gaida; U Fenger; Z Drzeniek; HD Haubeck; Christoph Wagener
Monoclonal, anti-domain and anti-peptide antibodies assign the molecular weight 160,000 granulocyte membrane antigen of the CD66 cluster to a mRNA species encoded by the biliary glycoprotein gene, a member of the carcinoembryonic antigen gene family.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(11):4978-84.
1992: F J Gaida; U Fenger; Christoph Wagener; Michael Neumaier
A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen.
International journal of cancer. Journal international du cancer 1992;51(3):459-65.
1990: Michael Neumaier; L Shively; F S Chen; F J Gaida; C Ilgen; R J Paxton; John E Shively; Arthur D Riggs
Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Cancer research 1990;50(7):2128-34.
1988: Y Hinoda; Michael Neumaier; S A Hefta; Z Drzeniek; Christoph Wagener; L Shively; LJ Hefta; John E Shively; R J Paxton
Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(18):6959-63.
1988: Michael Neumaier; W Zimmermann; L Shively; Y Hinoda; Arthur D Riggs; John E Shively
Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigen.
The Journal of biological chemistry 1988;263(7):3202-7.
1987: D Siepen; R J Paxton; Michael Neumaier; J E Shively; C Wagener
Carcinoembryonic antigen (CEA) and two crossreacting antigens of 165 kD and 105 kD isolated from meconium exhibit identical amino terminal sequences.
Biochemical and biophysical research communications 1987;147(1):212-8.
1986: Michael Neumaier; U Fenger; Christoph Wagener
Transblot studies with biotin-labeled proteins: electrophoretic mobilities and detection limits.
Analytical biochemistry 1986;156(1):76-80.
1985: Michael Neumaier; U Fenger; Christoph Wagener
Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(5):3604-9.
1985: Michael Neumaier; U Fenger; C Wagener
Delineation of four carcinoembryonic antigen (CEA) related antigens in normal plasma by transblot studies using monoclonal anti-CEA antibodies with different epitope specificities.
Molecular immunology 1985;22(11):1273-7.